{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T03:08:14Z","timestamp":1779160094661,"version":"3.51.4"},"reference-count":114,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["9575"],"award-info":[{"award-number":["9575"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004411","name":"Heart and Stroke Foundation of Canada","doi-asserted-by":"publisher","award":["G-14-0006060"],"award-info":[{"award-number":["G-14-0006060"]}],"id":[{"id":"10.13039\/100004411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.bbadis.2017.07.015","type":"journal-article","created":{"date-parts":[[2017,7,19]],"date-time":"2017-07-19T20:15:50Z","timestamp":1500495350000},"page":"1914-1922","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"PB","title":["Protecting the heart through MK2 modulation, toward a role in diabetic cardiomyopathy and lipid metabolism"],"prefix":"10.1016","volume":"1864","author":[{"given":"Matthieu","family":"Ruiz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lise","family":"Coderre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce Gordon","family":"Allen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Des Rosiers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2017.07.015_bb0005","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.bbadis.2017.01.016","article-title":"Dynamics of diabetes and obesity: epidemiological perspective","volume":"1863","author":"Boles","year":"2017","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2017.07.015_bb0010","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10741-012-9313-3","article-title":"Diabetic cardiomyopathy: pathophysiology and clinical features","volume":"18","author":"Miki","year":"2013","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.bbadis.2017.07.015_bb0015","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3390\/ijerph13020201","article-title":"Diabetes mellitus, arterial wall, and cardiovascular risk assessment","volume":"13","author":"Kozakova","year":"2016","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.bbadis.2017.07.015_bb0020","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2337\/diacare.27.1.201","article-title":"Risk factors for myocardial infarction case fatality and stroke case fatality in type 2 diabetes: UKPDS 66","volume":"27","author":"Stevens","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bbadis.2017.07.015_bb0025","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s11892-016-0809-4","article-title":"Heart failure: a major cardiovascular complication of diabetes mellitus","volume":"16","author":"Bahtiyar","year":"2016","journal-title":"Curr. Diabetes Rep."},{"key":"10.1016\/j.bbadis.2017.07.015_bb0030","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11154-010-9131-7","article-title":"Diabetic cardiomyopathy, causes and effects","volume":"11","author":"Boudina","year":"2010","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"10.1016\/j.bbadis.2017.07.015_bb0035","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1016\/j.ijcard.2013.07.150","article-title":"An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy","volume":"168","author":"Palomer","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.bbadis.2017.07.015_bb0040","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1161\/01.RES.0000199348.10580.1d","article-title":"Cardiac myocyte apoptosis is associated with increased DNA damage and decreased survival in murine models of obesity","volume":"98","author":"Barouch","year":"2006","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbadis.2017.07.015_bb0045","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.bbadis.2014.05.006","article-title":"Endoplasmic reticulum stress and protein quality control in diabetic cardiomyopathy","volume":"1852","author":"Yang","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2017.07.015_bb0050","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.pharmthera.2016.11.013","article-title":"Cardiac oxidative stress in diabetes: mechanisms and therapeutic potential","volume":"172","author":"Faria","year":"2016","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbadis.2017.07.015_bb0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006474","article-title":"Gene remodeling in type 2 diabetic cardiomyopathy and its phenotypic rescue with SERCA2a","volume":"4","author":"Karakikes","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2017.07.015_bb0060","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.jacc.2005.09.050","article-title":"The pathogenesis of myocardial fibrosis in the setting of diabetic cardiomyopathy","volume":"47","author":"Asbun","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbadis.2017.07.015_bb0065","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s10741-013-9385-8","article-title":"Mechanisms of subcellular remodeling in heart failure due to diabetes","volume":"19","author":"Dhalla","year":"2014","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.bbadis.2017.07.015_bb0070","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1089\/ars.2015.6349","article-title":"Diabetic cardiomyopathy and the role of mitochondrial dysfunction: novel insights, mechanisms, and therapeutic strategies","volume":"22","author":"Aon","year":"2015","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bbadis.2017.07.015_bb0075","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000433","article-title":"Taking diabetes to heart\u2014deregulation of myocardial lipid metabolism in diabetic cardiomyopathy","volume":"2","author":"Bayeva","year":"2013","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.bbadis.2017.07.015_bb0080","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/s00125-014-3171-6","article-title":"Molecular mechanisms of diabetic cardiomyopathy","volume":"57","author":"Bugger","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbadis.2017.07.015_bb0085","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1128\/MMBR.00031-10","article-title":"Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases","volume":"75","author":"Cargnello","year":"2011","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.bbadis.2017.07.015_bb0090","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.cell.2013.01.029","article-title":"SnapShot: p38 MAPK signaling","volume":"152","author":"Trempolec","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2017.07.015_bb0095","doi-asserted-by":"crossref","first-page":"R11","DOI":"10.1530\/JME-15-0146","article-title":"Stress kinases in the modulation of metabolism and energy balance","volume":"55","author":"Manieri","year":"2015","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.bbadis.2017.07.015_bb0100","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.cell.2013.01.047","article-title":"SnapShot: p38 MAPK substrates","volume":"152","author":"Trempolec","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2017.07.015_bb0105","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3390\/genes4020101","article-title":"The role of mitogen-activated protein kinase-activated protein kinases (MAPKAPKs) in inflammation","volume":"4","author":"Moens","year":"2013","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.bbadis.2017.07.015_bb0110","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/nrm1834","article-title":"MAPKAP kinases - MKs - two's company, three's a crowd","volume":"7","author":"Gaestel","year":"2006","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbadis.2017.07.015_bb0115","first-page":"515","article-title":"p38 inhibition and not MK2 inhibition enhances the secretion of chemokines from TNF-alpha activated rheumatoid arthritis fibroblast-like synoviocytes","volume":"31","author":"Dulos","year":"2013","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.bbadis.2017.07.015_bb0120","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1038\/embor.2008.149","article-title":"p38 alpha MAPK inhibits JNK activation and collaborates with IkappaB kinase 2 to prevent endotoxin-induced liver failure","volume":"9","author":"Heinrichsdorff","year":"2008","journal-title":"EMBO Rep."},{"key":"10.1016\/j.bbadis.2017.07.015_bb0125","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1042\/BJ20100323","article-title":"Mechanisms and functions of p38 MAPK signalling","volume":"429","author":"Cuadrado","year":"2010","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbadis.2017.07.015_bb0130","doi-asserted-by":"crossref","first-page":"520289","DOI":"10.1155\/2012\/520289","article-title":"New insights into the p38gamma and p38delta MAPK pathways","volume":"2012","author":"Risco","year":"2012","journal-title":"J. Signal. Transduct."},{"key":"10.1016\/j.bbadis.2017.07.015_bb0135","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1006\/jmcc.2001.1415","article-title":"Decreased p38 MAPK activity in end-stage failing human myocardium: p38 MAPK alpha is the predominant isoform expressed in human heart","volume":"33","author":"Lemke","year":"2001","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bbadis.2017.07.015_bb0140","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/j.cellsig.2010.06.002","article-title":"Effect of pressure overload-induced hypertrophy on the expression and localization of p38 MAP kinase isoforms in the mouse heart","volume":"22","author":"Dingar","year":"2010","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bbadis.2017.07.015_bb0145","first-page":"199","article-title":"The p38 MAP kinase family as regulators of proinflammatory cytokine production in degenerative diseases of the CNS","volume":"1","author":"Bachstetter","year":"2010","journal-title":"Aging Dis."},{"key":"10.1016\/j.bbadis.2017.07.015_bb0150","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.molmed.2009.06.005","article-title":"p38(MAPK): stress responses from molecular mechanisms to therapeutics","volume":"15","author":"Coulthard","year":"2009","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.bbadis.2017.07.015_bb0155","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.yjmcc.2010.10.021","article-title":"The p38 mitogen-activated protein kinase pathway\u2014a potential target for intervention in infarction, hypertrophy, and heart failure","volume":"51","author":"Marber","year":"2011","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bbadis.2017.07.015_bb0160","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1111\/bph.12901","article-title":"p38 MAPK in cardioprotection - are we there yet?","volume":"172","author":"Martin","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbadis.2017.07.015_bb0165","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s40256-014-0063-6","article-title":"Therapeutic potential of p38 MAP kinase inhibition in the management of cardiovascular disease","volume":"14","author":"Fisk","year":"2014","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"10.1016\/j.bbadis.2017.07.015_bb0170","doi-asserted-by":"crossref","first-page":"5793","DOI":"10.1093\/emboj\/cdg552","article-title":"Feedback control of the protein kinase TAK1 by SAPK2a\/p38alpha","volume":"22","author":"Cheung","year":"2003","journal-title":"EMBO J."},{"key":"10.1016\/j.bbadis.2017.07.015_bb0175","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nri3495","article-title":"Mitogen-activated protein kinases in innate immunity","volume":"13","author":"Arthur","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbadis.2017.07.015_bb0180","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.it.2013.03.007","article-title":"Cell type-specific function of TAK1 in innate immune signaling","volume":"34","author":"Ajibade","year":"2013","journal-title":"Trends Immunol."},{"key":"10.1016\/j.bbadis.2017.07.015_bb0185","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.cellsig.2007.12.003","article-title":"Activation of c-Jun N-terminal kinase (JNK) by widely used specific p38 MAPK inhibitors SB202190 and SB203580: a MLK-3-MKK7-dependent mechanism","volume":"20","author":"Muniyappa","year":"2008","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bbadis.2017.07.015_bb0190","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ejphar.2008.07.007","article-title":"SB203580, a pharmacological inhibitor of p38 MAP kinase transduction pathway activates ERK and JNK MAP kinases in primary cultures of human hepatocytes","volume":"593","author":"Henklova","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbadis.2017.07.015_bb0195","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1517\/14728222.12.8.921","article-title":"MK2: a novel molecular target for anti-inflammatory therapy","volume":"12","author":"Duraisamy","year":"2008","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.bbadis.2017.07.015_bb0200","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.246","article-title":"The interplay between inflammation and metabolism in rheumatoid arthritis","volume":"6","author":"Chimenti","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbadis.2017.07.015_bb0205","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.lfs.2017.01.003","article-title":"Chronoinflammaging in Alzheimer; a systematic review on the roles of toll like receptor 2","volume":"171","author":"Ravari","year":"2017","journal-title":"Life Sci."},{"key":"10.1016\/j.bbadis.2017.07.015_bb0210","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nature01323","article-title":"Inflammation in atherosclerosis","volume":"420","author":"Libby","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2017.07.015_bb0215","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1083\/jcb.201412052","article-title":"Recent insights into the cellular biology of atherosclerosis","volume":"209","author":"Tabas","year":"2015","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbadis.2017.07.015_bb0220","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/jcb.24402","article-title":"Role of inflammatory mechanisms in pathogenesis of type 2 diabetes mellitus","volume":"114","author":"Akash","year":"2013","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bbadis.2017.07.015_bb0225","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.bbadis.2014.06.030","article-title":"Interplay of oxidative, nitrosative\/nitrative stress, inflammation, cell death and autophagy in diabetic cardiomyopathy","volume":"1852","author":"Varga","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2017.07.015_bb0230","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12929-016-0303-y","article-title":"Mechanisms of inflammatory responses and development of insulin resistance: how are they interlinked?","volume":"23","author":"Rehman","year":"2016","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.bbadis.2017.07.015_bb0235","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/372739a0","article-title":"A protein kinase involved in the regulation of inflammatory cytokine biosynthesis","volume":"372","author":"Lee","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2017.07.015_bb0240","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0014-5793(96)00816-2","article-title":"A comparison of the substrate specificity of MAPKAP kinase-2 and MAPKAP kinase-3 and their activation by cytokines and cellular stress","volume":"392","author":"Clifton","year":"1996","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbadis.2017.07.015_bb0245","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1515\/hsz-2013-0197","article-title":"What goes up must come down: molecular basis of MAPKAP kinase 2\/3-dependent regulation of the inflammatory response and its inhibition","volume":"394","author":"Gaestel","year":"2013","journal-title":"Biol. Chem."},{"key":"10.1016\/j.bbadis.2017.07.015_bb0250","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1161\/CIRCRESAHA.109.213199","article-title":"MAPK-activated protein kinase-2 in cardiac hypertrophy and cyclooxygenase-2 regulation in heart","volume":"106","author":"Streicher","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbadis.2017.07.015_bb0255","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1074\/jbc.C100685200","article-title":"MK2 targets AU-rich elements and regulates biosynthesis of tumor necrosis factor and interleukin-6 independently at different post-transcriptional levels","volume":"277","author":"Neininger","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2017.07.015_bb0260","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1002977","article-title":"The p38\/MK2-driven exchange between tristetraprolin and HuR regulates AU-rich element-dependent translation","volume":"8","author":"Tiedje","year":"2012","journal-title":"PLoS Genet."},{"key":"10.1016\/j.bbadis.2017.07.015_bb0265","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/sj.emboj.7600163","article-title":"MK2-induced tristetraprolin:14-3-3 complexes prevent stress granule association and ARE-mRNA decay","volume":"23","author":"Stoecklin","year":"2004","journal-title":"EMBO J."},{"key":"10.1016\/j.bbadis.2017.07.015_bb0270","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1128\/MCB.00717-10","article-title":"Phosphorylation of tristetraprolin by MK2 impairs AU-rich element mRNA decay by preventing deadenylase recruitment","volume":"31","author":"Clement","year":"2011","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbadis.2017.07.015_bb0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/jir.2005.25.1","article-title":"The AU-rich transcriptome: more than interferons and cytokines, and its role in disease","volume":"25","author":"Khabar","year":"2005","journal-title":"J. Interf. Cytokine Res."},{"key":"10.1016\/j.bbadis.2017.07.015_bb0280","doi-asserted-by":"crossref","first-page":"64","DOI":"10.2337\/db07-0832","article-title":"Acute diabetes moderates trafficking of cardiac lipoprotein lipase through p38 mitogen-activated protein kinase-dependent actin cytoskeleton organization","volume":"57","author":"Kim","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.bbadis.2017.07.015_bb0285","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1194\/jlr.R800085-JLR200","article-title":"Regulation of fatty acid uptake into tissues: lipoprotein lipase- and CD36-mediated pathways","volume":"50","author":"Goldberg","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbadis.2017.07.015_bb0290","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1152\/jappl.2001.91.2.963","article-title":"Invited review: focal adhesion and small heat shock proteins in the regulation of actin remodeling and contractility in smooth muscle","volume":"91","author":"Gerthoffer","year":"2001","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.bbadis.2017.07.015_bb0295","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1124\/mol.113.090365","article-title":"Mitogen-activated protein kinase-activated protein kinase 2 in neuroinflammation, heat shock protein 27 phosphorylation, and cell cycle: role and targeting","volume":"85","author":"Gurgis","year":"2014","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbadis.2017.07.015_bb0300","doi-asserted-by":"crossref","first-page":"14793","DOI":"10.1074\/jbc.M111945200","article-title":"Arachidonic acid promotes phosphorylation of 5-lipoxygenase at Ser-271 by MAPK-activated protein kinase 2 (MK2)","volume":"277","author":"Werz","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2017.07.015_bb0305","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1111\/febs.12759","article-title":"Analysis of 5-lipoxygenase phosphorylation on molecular level by MALDI-MS","volume":"281","author":"Markoutsa","year":"2014","journal-title":"FEBS J."},{"key":"10.1016\/j.bbadis.2017.07.015_bb0310","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev.pharmtox.011008.145616","article-title":"Lipid mediators in health and disease: enzymes and receptors as therapeutic targets for the regulation of immunity and inflammation","volume":"49","author":"Shimizu","year":"2009","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.bbadis.2017.07.015_bb0315","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1128\/MCB.01456-06","article-title":"The mitogen-activated protein kinase (MAPK)-activated protein kinases MK2 and MK3 cooperate in stimulation of tumor necrosis factor biosynthesis and stabilization of p38 MAPK","volume":"27","author":"Ronkina","year":"2007","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbadis.2017.07.015_bb0320","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1002\/jcb.22675","article-title":"Mechanisms regulating the nuclear translocation of p38 MAP kinase","volume":"110","author":"Gong","year":"2010","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bbadis.2017.07.015_bb0325","doi-asserted-by":"crossref","first-page":"4827","DOI":"10.1128\/MCB.22.13.4827-4835.2002","article-title":"Distinct cellular functions of MK2","volume":"22","author":"Kotlyarov","year":"2002","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbadis.2017.07.015_bb0330","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s12192-009-0101-5","article-title":"MAPKAPK-2 modulates p38-MAPK localization and small heat shock protein phosphorylation but does not mediate the injury associated with p38-MAPK activation during myocardial ischemia","volume":"14","author":"Gorog","year":"2009","journal-title":"Cell Stress Chaperones"},{"key":"10.1016\/j.bbadis.2017.07.015_bb0335","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.yjmcc.2004.10.018","article-title":"MK2\u2212\/\u2212 gene knockout mouse hearts carry anti-apoptotic signal and are resistant to ischemia reperfusion injury","volume":"38","author":"Shiroto","year":"2005","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bbadis.2017.07.015_bb0340","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1478-811X-12-6","article-title":"A p38MAPK\/MK2 signaling pathway leading to redox stress, cell death and ischemia\/reperfusion injury","volume":"12","author":"Ashraf","year":"2014","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.bbadis.2017.07.015_bb0345","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.yjmcc.2014.09.011","article-title":"MMI-0100 inhibits cardiac fibrosis in myocardial infarction by direct actions on cardiomyocytes and fibroblasts via MK2 inhibition","volume":"77","author":"Xu","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bbadis.2017.07.015_bb0350","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.vph.2011.07.008","article-title":"Inhibition of Mitogen Activated Protein Kinase Activated Protein Kinase II with MMI-0100 reduces intimal hyperplasia ex vivo and in vivo","volume":"56","author":"Muto","year":"2012","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.bbadis.2017.07.015_bb0355","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1165\/rcmb.2012-0389OC","article-title":"Peptide-mediated inhibition of mitogen-activated protein kinase-activated protein kinase-2 ameliorates bleomycin-induced pulmonary fibrosis","volume":"49","author":"Vittal","year":"2013","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.bbadis.2017.07.015_bb0360","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1161\/CIRCRESAHA.112.272963","article-title":"Unrestrained p38 MAPK activation in Dusp1\/4 double-null mice induces cardiomyopathy","volume":"112","author":"Auger-Messier","year":"2013","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbadis.2017.07.015_bb0365","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1128\/MCB.01692-12","article-title":"Mitogen-activated protein kinase-activated protein kinases 2 and 3 regulate SERCA2a expression and fiber type composition to modulate skeletal muscle and cardiomyocyte function","volume":"33","author":"Scharf","year":"2013","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbadis.2017.07.015_bb0370","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1748-1716.2007.01800.x","article-title":"Adenosine increases calcium sensitivity via receptor-independent activation of the p38\/MK2 pathway in mesenteric arteries","volume":"193","author":"Martinka","year":"2008","journal-title":"Acta Physiol. (Oxford)"},{"key":"10.1016\/j.bbadis.2017.07.015_bb0375","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1161\/HYPERTENSIONAHA.110.159889","article-title":"Mitogen-activated protein kinase-activated protein kinase 2 in angiotensin II-induced inflammation and hypertension: regulation of oxidative stress","volume":"57","author":"Ebrahimian","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.bbadis.2017.07.015_bb0380","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1161\/CIRCRESAHA.107.156075","article-title":"Systemic deficiency of the MAP kinase-activated protein kinase 2 reduces atherosclerosis in hypercholesterolemic mice","volume":"101","author":"Jagavelu","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbadis.2017.07.015_bb0385","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.3390\/ijms17071037","article-title":"The role of p38 MAPK in the development of diabetic cardiomyopathy","volume":"17","author":"Wang","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbadis.2017.07.015_bb0390","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1007\/s00125-006-0385-2","article-title":"Inhibition of p38 mitogen-activated protein kinase attenuates left ventricular dysfunction by mediating pro-inflammatory cardiac cytokine levels in a mouse model of diabetes mellitus","volume":"49","author":"Westermann","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbadis.2017.07.015_bb0395","doi-asserted-by":"crossref","first-page":"H911","DOI":"10.1152\/ajpheart.00124.2009","article-title":"Dominant-negative p38alpha mitogen-activated protein kinase prevents cardiac apoptosis and remodeling after streptozotocin-induced diabetes mellitus","volume":"297","author":"Thandavarayan","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bbadis.2017.07.015_bb0400","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.cmet.2013.10.011","article-title":"Activation of calcium\/calmodulin-dependent protein kinase II in obesity mediates suppression of hepatic insulin signaling","volume":"18","author":"Ozcan","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbadis.2017.07.015_bb0405","doi-asserted-by":"crossref","DOI":"10.2337\/db14-1945","article-title":"Treatment of obese insulin-resistant mice with an allosteric MAPKAPK2\/3 inhibitor lowers blood glucose and improves insulin sensitivity","author":"Ozcan","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.bbadis.2017.07.015_bb0410","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2337\/db15-0238","article-title":"MK2 deletion in mice prevents diabetes-induced perturbations in lipid metabolism and cardiac dysfunction","volume":"65","author":"Ruiz","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.bbadis.2017.07.015_bb0415","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/cphy.c130024","article-title":"Energy metabolism in the liver","volume":"4","author":"Rui","year":"2014","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.bbadis.2017.07.015_bb0420","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/1753-0407.12239","article-title":"Identification of a definite diabetic cardiomyopathy in type 2 diabetes by comprehensive echocardiographic evaluation: a cross-sectional comparison with non-diabetic weight-matched controls","volume":"7","author":"Ofstad","year":"2015","journal-title":"J. Diabetes"},{"key":"10.1016\/j.bbadis.2017.07.015_bb0425","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1177\/0960327112450885","article-title":"Diabetic cardiomyopathy: pathophysiological mechanisms and cardiac dysfuntion","volume":"32","author":"Goyal","year":"2013","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.bbadis.2017.07.015_bb0430","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.yjmcc.2013.12.005","article-title":"p38alpha regulates SERCA2a function","volume":"67","author":"Kaikkonen","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bbadis.2017.07.015_bb0435","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/nrm1151","article-title":"Phospholamban: a crucial regulator of cardiac contractility","volume":"4","author":"MacLennan","year":"2003","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbadis.2017.07.015_bb0440","doi-asserted-by":"crossref","first-page":"H532","DOI":"10.1152\/ajpheart.00765.2015","article-title":"CaMKII-dependent phosphorylation regulates basal cardiac pacemaker function via modulation of local Ca2+ releases","volume":"311","author":"Li","year":"2016","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bbadis.2017.07.015_bb0445","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/(SICI)1520-7560(199911\/12)15:6<412::AID-DMRR72>3.0.CO;2-8","article-title":"Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes","volume":"15","author":"Laffel","year":"1999","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.bbadis.2017.07.015_bb0450","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2337\/db12-0466","article-title":"Acylcarnitines: reflecting or inflicting insulin resistance?","volume":"62","author":"Schooneman","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.bbadis.2017.07.015_bb0455","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nm.2307","article-title":"Metabolite profiles and the risk of developing diabetes","volume":"17","author":"Wang","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbadis.2017.07.015_bb0460","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nrendo.2014.171","article-title":"Branched-chain amino acids in metabolic signalling and insulin resistance","volume":"10","author":"Lynch","year":"2014","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.bbadis.2017.07.015_bb0465","doi-asserted-by":"crossref","first-page":"E1175","DOI":"10.1152\/ajpendo.00630.2012","article-title":"Regulation of adipose branched-chain amino acid catabolism enzyme expression and cross-adipose amino acid flux in human obesity","volume":"304","author":"Lackey","year":"2013","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.bbadis.2017.07.015_bb0470","doi-asserted-by":"crossref","first-page":"11348","DOI":"10.1074\/jbc.M109.075184","article-title":"Adipose tissue branched chain amino acid (BCAA) metabolism modulates circulating BCAA levels","volume":"285","author":"Herman","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2017.07.015_bb0475","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nchembio.1961","article-title":"Branched-chain amino acid catabolism fuels adipocyte differentiation and lipogenesis","volume":"12","author":"Green","year":"2016","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.bbadis.2017.07.015_bb0480","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/j.bbalip.2016.02.011","article-title":"Lipotoxicity in obesity and diabetes-related cardiac dysfunction","volume":"1860","author":"Zlobine","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2017.07.015_bb0485","doi-asserted-by":"crossref","first-page":"H2096","DOI":"10.1152\/ajpheart.00452.2009","article-title":"Type 1 diabetic cardiomyopathy in the Akita (Ins2WT\/C96Y) mouse model is characterized by lipotoxicity and diastolic dysfunction with preserved systolic function","volume":"297","author":"Basu","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bbadis.2017.07.015_bb0490","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1194\/jlr.R200009-JLR200","article-title":"Hormone-sensitive lipase: control of intracellular tri-(di-)acylglycerol and cholesteryl ester hydrolysis","volume":"43","author":"Kraemer","year":"2002","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbadis.2017.07.015_bb0495","doi-asserted-by":"crossref","first-page":"43074","DOI":"10.1074\/jbc.M308484200","article-title":"Role of AMP-activated protein kinase in cyclic AMP-dependent lipolysis In 3T3-L1 adipocytes","volume":"278","author":"Yin","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2017.07.015_bb0500","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1432-1033.1989.tb14548.x","article-title":"Phosphorylation of bovine hormone-sensitive lipase by the AMP-activated protein kinase. A possible antilipolytic mechanism","volume":"179","author":"Garton","year":"1989","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bbadis.2017.07.015_bb0505","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S0008-6363(03)00469-3","article-title":"Circulating triglyceride lipolysis facilitates lipoprotein lipase translocation from cardiomyocyte to myocardial endothelial lining","volume":"59","author":"Pulinilkunnil","year":"2003","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbadis.2017.07.015_bb0510","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1161\/01.ATV.17.11.2532","article-title":"Correction of hypertriglyceridemia and impaired fat tolerance in lipoprotein lipase-deficient mice by adenovirus-mediated expression of human lipoprotein lipase","volume":"17","author":"Excoffon","year":"1997","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbadis.2017.07.015_bb0515","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/j.bbalip.2016.03.016","article-title":"Cardiomyocyte-endothelial cell control of lipoprotein lipase","volume":"1860","author":"Chiu","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2017.07.015_bb0520","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.2337\/diabetes.53.7.1655","article-title":"Enhanced sarcolemmal FAT\/CD36 content and triacylglycerol storage in cardiac myocytes from obese zucker rats","volume":"53","author":"Coort","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.bbadis.2017.07.015_bb0525","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1007\/s00125-007-0735-8","article-title":"Cardiac contractile dysfunction in insulin-resistant rats fed a high-fat diet is associated with elevated CD36-mediated fatty acid uptake and esterification","volume":"50","author":"Ouwens","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbadis.2017.07.015_bb0530","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1126\/science.7678183","article-title":"Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance","volume":"259","author":"Hotamisligil","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2017.07.015_bb0535","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/nri2449","article-title":"Nutrient sensing and inflammation in metabolic diseases","volume":"8","author":"Hotamisligil","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbadis.2017.07.015_bb0540","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/10061","article-title":"MAPKAP kinase 2 is essential for LPS-induced TNF-alpha biosynthesis","volume":"1","author":"Kotlyarov","year":"1999","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbadis.2017.07.015_bb0545","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1126\/science.294.5548.1871","article-title":"Prostaglandins and leukotrienes: advances in eicosanoid biology","volume":"294","author":"Funk","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2017.07.015_bb0550","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/sj.ijo.0803147","article-title":"ALOX5AP expression, but not gene haplotypes, is associated with obesity and insulin resistance","volume":"30","author":"Kaaman","year":"2006","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.bbadis.2017.07.015_bb0555","doi-asserted-by":"crossref","first-page":"262","DOI":"10.4161\/adip.24835","article-title":"A role for 5-lipoxygenase products in obesity-associated inflammation and insulin resistance","volume":"2","author":"Neels","year":"2013","journal-title":"Adipocytes"},{"key":"10.1016\/j.bbadis.2017.07.015_bb0560","doi-asserted-by":"crossref","first-page":"3978","DOI":"10.4049\/jimmunol.0901355","article-title":"5-lipoxygenase activating protein signals adipose tissue inflammation and lipid dysfunction in experimental obesity","volume":"184","author":"Horrillo","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbadis.2017.07.015_bb0565","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.2337\/db11-1455","article-title":"Adipocytes secrete leukotrienes: contribution to obesity-associated inflammation and insulin resistance in mice","volume":"61","author":"Mothe-Satney","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.bbadis.2017.07.015_bb0570","doi-asserted-by":"crossref","first-page":"H991","DOI":"10.1152\/ajpheart.00789.2015","article-title":"Ivabradine and metoprolol differentially affect cardiac glucose metabolism despite similar heart rate reduction in a mouse model of dyslipidemia","volume":"311","author":"Vaillant","year":"2016","journal-title":"Am. J. Physiol. Heart Circ. Physiol."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443917302417?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443917302417?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T10:45:17Z","timestamp":1565347517000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443917302417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":114,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0925443917302417"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2017.07.015","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protecting the heart through MK2 modulation, toward a role in diabetic cardiomyopathy and lipid metabolism","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2017.07.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V.","name":"copyright","label":"Copyright"}]}}